EQUITY RESEARCH MEMO

Yashraj Biotechnology

Generated 5/24/2026

Executive Summary

Conviction (model self-assessment)55/100

Yashraj Biotechnology is a privately held biopharmaceutical company headquartered in Mumbai, India, founded in 2020. The company focuses on the development and manufacturing of vaccines, biologics, and diagnostic kits for both human and animal health. With a commercial-stage operations, Yashraj aims to address unmet medical needs in the Indian and global markets. Its product portfolio spans preventive vaccines, therapeutic biologics, and rapid diagnostic tests, leveraging in-house R&D and manufacturing capabilities. The company's mission is to provide affordable and accessible healthcare solutions, particularly in underserved regions.

Upcoming Catalysts (preview)

  • TBDLaunch of new vaccine for endemic diseases60% success
  • TBDStrategic partnership or licensing deal with global pharma40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)